DALLAS, March 06, 2018 -- Via OTC PR Wire -- Puration, Inc. (USOTC:PURA) wrapped up its launch event at the 30th Annual Arnold Sports Festival in Columbus, Ohio on Sunday reporting an across the board win. Puration’s new Kiwi-Strawberry and Lemmon-Lime flavored EVERx CBD Infused Sports Waters were a hit with athletes and fans. To top off the launch event, EVERx sponsored, main event MMA fighter Cee Jay Hamilton won in a packed arena on Saturday night. Puration signed a 30 pallet order at the event and anticipates several additional larger orders to follow.
|
|||||||||||||||
EVERx Sports Water is built on two patents that together deliver a combination of characteristics that are unprecedented in the beverage industry. In addition to the benefits of its CBD infusions, EVERx Sports Water has an optimal alkaline pH level formulated with antioxidants and electrolytes to deliver the most effective hydration available in the alkaline water market. EVERx was popular at the show with both competitors and fitness enthusiasts of all ages.
Look for information on the EVERx experience at the Arnold coming later this week.
For more information on EVERx, visit http://www.drinkeverx.com.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
Photos accompanying this announcement are available:
http://www.globenewswire.com/NewsRoom/AttachmentNg/370ee293-b928-4c63-a127-ceccfc1b8723
http://www.globenewswire.com/NewsRoom/AttachmentNg/c93314a3-40fb-45e2-8451-6622e2c7b849
http://www.globenewswire.com/NewsRoom/AttachmentNg/5a579f83-e0c8-4edb-96b4-e0555b7a2079


Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
OpenAI Restricts Astra AI Over Cyberattack Risks
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



